Evaluation of the Patient with Dyspepsia

,

Applied Evidence

Evaluation of the Patient with Dyspepsia

J Fam Pract. 2001 June;50(6):538-543

References

1. Talley N, Stanghellini V, Heading R, et al. Functional gastroduodenal disorders. Gut 1999;45:1137-42.

2. Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol 1999;34(suppl):3-8.

3. Jones RH, Lydeard SE, Hobbs FDR, Kenkre JE, Williams EI, Jones SJ. Dyspepsia in England and Scotland. Gut 1990;31:401-05.

4. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102:1259-68.

5. Marsland DW, Wood M, Mayo F. Content of family practice. Part I: rank order of diagnoses by frequency. Part II: diagnoses by disease category and age/sex distribution. J Fam Pract 1976;3:37-68.

6. Dimenas E. Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases. Scand J Gastroenterol 1993;28(suppl):18-21.

7. Rabeneck L, Wray NP, Graham DY. Managing dyspepsia: what do we know and what do we need to know? Am J Gastroenterol 1998;93:920-24.

8. McNamara DA, Buckley M, O’Morain CA. Nonulcer dyspepsia: current concepts and management. Gastroenterol Clin N Am 2000;29:807-18.

9. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. Gastroenterology 1998;114:582-95.

10. Lundquist P, Seensalu R, Linden B, Nilsson LH, Lindberg G. Symptom criteria do not distinguish between functional and organic dyspepsia. Eur J Surg 1998;164:345-52.

11. Heikkinen MT, Pikkarainen PH, Takala JK, Rasanen HT, Eskelinen MJ, Julkunen RJK. Diagnostic methods in dyspepsia: the usefulness of upper abdominal ultrasound and gastroscopy. Scand J Prim Health Care 1997;15:82-86.

12. Crean GP, Holden RJ, Knill-Jones RP, et al. A database on dyspepsia. Gut 1994;35:191-202.

13. Christie J, Shepherd NA, Codling BW, Valori RM. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 1997;41:513-17.

14. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer: nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997;24:2-17.

15. Johannessen T, Petersen H, Kleveland PM, et al. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990;25:689-97.

16. Mansi C, Savarino V, Mela GS, Picciotto A, Mele MR, Cele G. Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. Am J Gastroenterol 1993;88:1011-15.

17. Talley NJ, McNeil D, Piper DW. Discriminant value of dyspeptic symptoms: a study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis. Gut 1987;28:40-46.

18. Numans M, van der Graaf Y, de Wit NJ, Touw-otten FWMM, de Melker RA. How much ulcer is ulcer-like? Diagnostic determinates of peptic ulcer in open access gastroscopy. Fam Pract 1994;11:382-88.

19. Bytzer P, Moller Hansen J, de Muckadell OBS, Malchow-Moller A. Predicting endoscopic diagnosis in the dyspeptic patient: the value of predictive score models. Scand J Gastroenterol 1997;32:118-25.

20. Priebe WM, DaCosta LR, Beck IT. Is epigastric tenderness a sign of peptic ulcer disease? Gastroenterology 1982;82:16-19.

21. Heikkinen M, Pikkarainen P, Eskelinen M, Julkunen R. GPs’ ability to diagnose dyspepsia based only on physical examination and patient history. Scand J Prim Health Care 2000;18:99-104.

22. Ofman JJ, Etchason J, Fullerton S, Kahn KL, Soll AH. Management strategies for Helicobacter pylori–seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med 1997;126:280-91.

23. Shaw PC, van Romunde LKJ, Griffioen G, Janssens AR, Kreuning J, Eilers GAM. Peptic ulcer and gastric carcinoma: diagnosis with biphasic radiography compared with fiberoptic endoscopy. Radiology 1987;163:39-42.

24. Dooley CP, Larson AW, Stace NH, Renner IG, Valenzuela JE, Eliasoph J. Double-contrast barium meal and upper gastrointestinal endoscopy: a comparative study. Ann Intern Med 1984;101:538-45.

25. Quartero AO, de Wit NJ, Lodder AC, Numans ME, Smout AJPM, Hoes AW. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998;43:2028-33.

26. Peterson W, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L. Helicobacter pylori–related disease: guidelines for testing and treatment. Arch Intern Med 2000;160:1285-91.

27. Moore RA. Helicobacter pylori and peptic ulcer: a systematic review of effectiveness and an overview of the economic benefits of implementing what is known to be effective. Oxford: Pain Relief Research Unit, 1995; vii:37.

28. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996;110:1244-52.

29. Laheij RJF, Straatman H, Jansen JBMJ, Verbeek ALM. Evaluation of commercially available Helicobacter pylori serology kits: a review. J Clin Microbiol 1998;36:2803-09.

30. Chey WD, Murthy U, Shaw S, et al. A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial. Am J Gastroenterol 1999;94:1512-16.

31. Faigel DO, Magaret N, Corless C, Lieberman DA, Fennerty MB. Evaluation of rapid antibody tests for the diagnosis of Helicobacter pylori infection. Am J Gastroenterol 2000;95:72-77.

32. Ho B, Marshall BJ. Accurate diagnosis of Helicobacter pylori: serologic testing. Gastroenterol Clin N Am 2000;29:853-62.

33. Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995;109:136-41.

34. Thijs JC, van Zwet AA, Thijs WJ, et al. Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol 1996;91:2125-29.

35. Vaira D, Malfertheiner P, Megraud F, et al. Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. Lancet 1999;354:30-33.

36. Vaira D, Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori. Gut 2001;48:287-89.

37. American Gastroenterological Association. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 1998;114:579-81.

38. Hunt RH, Fallone CA, Thomson ABR. Canadian Helicobacter Study Group. Canadian Helicobacter pylori consensus conference update: infection in adults. Can J Gastroenterol 1999;13:213-17.

39. The European Helicobacter Pylori Study Group (EHPSG). Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus Report. Gut 1997;41:8-13.

40. Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis. Yale J Biol Med 1996;69:187-95.

41. Ebell MH, Warbasse L, Brenner C. Evaluation of the dyspeptic patient: a cost-utility study. J Fam Pract 1997;44:545-55.

42. Lassen AT, Pedersen FM, Bytzer P, de Muckadell OBS. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000;356:455-60.

43. Jones R, Tait C, Sladen G, Weston-Baker J. A trial of test-and-treat strategy for Helicobacter pylori–positive dyspeptic patients in general practice. Int J Clin Pract 1999;53:413-16.

44. Heaney A, Collins JSA, Watson RGP, McFarland RJ, Bamford KB, Tham TCK. A prospective randomised trial of a “test and treat” policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut 1999;45:186-90.

45. Asante MA, Mendall M, Patel P, Ballam L, Northfield TC. A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia. Eur J Gastroenterol Hepatol 1998;10:983-89.

46. Tovey FI, Hobsley M. Is Helicobacter pylori the primary cause of duodenal ulceration? J Gastroenterol Hepatol 1999;14:1053-56.

47. Xia HHX, Kalantar JS, Mitchell HM, Talley NJ. Can Helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther 2000;14:615-24.

48. Hirth RA, Bloom BS, Chernew ME, Fendrick AM. Patient, physician, and payer perceptions and misperceptions of willingness to pay for diagnostic certainty. Int J Technol Assess Health Care 2000;16:35-49.

49. Kurata JH, Nogawa AN, Chen YK, Parker CE. Dyspepsia in primary care: perceived causes, reasons for improvement, and satisfaction with care. J Fam Pract 1997;44:281-88.

50. Peura DA, Pambianco DJ, Dye KR, et al. Microdose 14C-urea breath test offers diagnosis of Helicobacter pylori in 10 minutes. Am J Gastroenterol 1996;91:233-38.

51. Raju GS, Smith MJ, Morton D, Bardhan KD. Mini-dose (1-microCi) 14C-urea breath test for the detection of Helicobacter pylori. Am J Gastroenterol 1994;89:1027-31.

The most recent American, Canadian, and European consensus-based guidelines all recommend that patients younger than 45 years with dyspepsia and no alarm symptoms should be tested for H pylori infection and then given eradication therapy if positive; patients older than 45 years and those with alarm symptoms should have prompt endoscopy.^37-39 H pylori–negative patients younger than 45 years and without alarm symptoms should be managed empirically for functional dyspepsia. H pylori–positive or negative patients who do not undergo endoscopy initially should do so if their symptoms persist. An algorithm depicting this approach is presented in the Figure 1. Cost-effectiveness analyses generally support this approach.^22,40,41

Direct evidence for these approaches from randomized controlled trials has recently become available.^42-45 These studies show that outcomes are similar whether patients received prompt endoscopy or follow a test and treat strategy. Note that patients older than 45 years, using NSAIDs, or with any alarm symptoms for complicated disease were either excluded from these trials or underwent prompt endoscopy.

Although the current evidence supports a test and treat strategy, the results may not be generalizable to all areas. The effectiveness of this approach depends on the prevalence of H pylori infection in patients with ulcers in the community; in some areas, this prevalence may be too low to make this approach effective.^46,47 Also, patients not undergoing prompt endoscopy may be less satisfied with their care,⁴² which is related to the observation that patients with dyspepsia are more likely than physicians to value diagnostic certainty.⁴⁸ Other data suggest, however, that patient satisfaction is more closely associated with symptom improvement than with having procedures performed.⁴⁹ With these caveats in mind, it seems most reasonable to inform your patients about the evidence regarding the advantages and disadvantages of the various approaches and allow them to share in the decision-making process.